article thumbnail

The rising impact of biomarkers in early clinical development

Drug Target Review

The context of use (COU) of biomarker assays must be firmly established, clearly and comprehensively citing how they should be used, and the regulated product development and review-related purpose of that use. Biomarkers can play a crucial role throughout clinical development, especially in early phases.

article thumbnail

Harnessing AI and Real-World Data: The Future of Clinical Development

PPD

Machine learning is a subset of AI that identifies patterns in large datasets, leveraging identifiable conditions or attributes that are needed to inform sample selection for trials and other prospective data. It identifies cases in instances where diagnosis codes and other information available in each database are too non-specific to do so.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

9 Ways Worldwide Optimizes Clinical Development for Your Biotech Growth Journey

Conversations in Drug Development Trends

Selecting the right CRO to partner with on your development program is a pivotal decision that can shape the trajectory of your product’s development. Our consultative approach ensures success by integrating research methodology, regulatory affairs strategy, and clinical operations. You can expect transparency.

article thumbnail

CMC Content for Global Clinical Development of Pharmaceuticals

The Premier Consulting Blog

As clinical development of an investigational product proceeds, Sponsors often conduct global clinical trials which require preparation of content to support dossiers in multiple geographies, meeting the regulatory requirements of each region. Drug substance content in Module 3.2.S

article thumbnail

AlgoTherapeutix Receives Regulatory Approval to Initiate Clinical Development of ATX01

The Pharma Data

AlgoTherapeutix recently raised a 12M€ Series A that will fund the Phase 1 and 2 clinical development of ATX01. About AlgoTherapeutix AlgoTx was founded in 2018 by Stéphane Thiroloix and Olivier Bohuon to develop topical treatments for complex pain and was incubated by Paris Biotech Santé. Source link.

article thumbnail

The Evolution of Adaptive Protocols: Early Clinical Development

PPD

The possibility for change needs to be ethically sound and clear to all involved, including investigators, site staff and cross-functional team members, like clinical monitors, statisticians, data managers and vendors. Each step of the process is conducted with an eye toward supporting later-phase programs and regulatory submissions.

article thumbnail

Getting the Pulse on Biopharma and Biotech Companies: Differing Perspectives on Clinical Development

PPD

To keep a pulse on this rapidly changing industry, the PPD clinical research business of Thermo Fisher Scientific surveyed 150 leaders in the biopharma and biotech industries for the second consecutive year. Differences in size, resources and agility have led the two groups to take different approaches to clinical development.